A challenging economic environment is constricting biotech deal flow. But for well-capitalized Lantheus, these tough times ...

Short interest in Lantheus Holdings Inc (NASDAQ:LNTH) decreased during the last reporting period, falling from 6.46M to 6.42M. This put 12.34% of the company's publicly available shares short.

Lantheus Holdings, Inc. has a 52 week low of $58.46 and a 52 week high of $126.89. The company’s 50-day moving average price is $93.32 and its two-hundred day moving average price is $95.80.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Lantheus Holdings, Inc. has a 52 week low of $58.46 and a 52 week high of $126.89. The stock has a market cap of $6.23 billion, a P/E ratio of 15.13 and a beta of 0.38. Want More Great Investing ...

Below is Validea's guru fundamental report for LANTHEUS HOLDINGS INC (LNTH). Of the 22 guru strategies we follow, LNTH rates highest using our Twin Momentum Investor model based on the published ...

BEDFORD, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical ...

BEDFORD, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling ...

BEDFORD, Mass. - Lantheus Holdings, Inc. (NASDAQ: LNTH), a leader in the radiopharmaceutical industry, announced today the completion of its acquisition of Evergreen Theragnostics, Inc., a ...

BEDFORD, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to ...

BEDFORD, Mass. - Lantheus Holdings, Inc. (NASDAQ: LNTH), a leader in the radiopharmaceutical industry, announced today the completion of its acquisition of Evergreen Theragnostics, Inc., a ...